Sophie Harding

Sophie Harding registered as a pharmacist in 2004 and has 17 years' experience within oncology services. In 2020, she co-led the implementation of DPYD testing alongside senior medical colleagues, which was later rolled out across Wales by the All Wales Medical Genomics Service (AWMGS), winning a MediWales award in 2021. The first pharmacist Genomics Champion in Wales, she also co-led the set-up of the National Pharmacogenomics Group (NPGG) in Wales in 2022.

Between 2022 and 2023, she was Pharmacogenomics Lead for Great Britain at the Royal Pharmaceutical Society (RPS), leading on the development of national policy and advocacy for the role of pharmacy in pharmacogenomics, and later co-led the development of the HEIW Strategic Genomics Workforce Plan for Wales.

In July 2024, she became All Wales Consultant Pharmacist for Pharmacogenomics, aiming to support and strategically lead the implementation of pharmacogenomic testing within clinical practice by collaborating with clinical teams across Wales. She is currently leading on the development of a Pharmacogenomic Delivery Plan for Wales, and is an active researcher at Swansea University, trained to doctoral level.